Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Low-dose oral minoxidil is generally safe for hypertensive patients with hair loss.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Morroniside has many health benefits, including protection against diabetes complications, bone and brain diseases, heart and skin issues, and it supports hair growth and reduces inflammation.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

A new method using hyaluronic acid liposomes improves Minoxidil's effectiveness and safety for hair growth treatment.

Dutasteride may protect the brain in early Parkinson's disease.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Minoxidil and 4-MA can help treat hair loss.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

A patient with complete hair loss regrew all her hair using tofacitinib.

A man developed heart problems after using a baldness treatment for 4 months, suggesting that people with heart issues should avoid this treatment.

Combination therapy improves hair growth in advanced hair loss.

Tofacitinib is a promising treatment for children with rheumatic diseases.

New 5% minoxidil formula safely and effectively treats male hair loss.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.